Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC. [electronic resource]
Producer: 20080702Description: 122-30 p. digitalISSN:- 0271-9142
- Adult
- Dose-Response Relationship, Drug
- Female
- Gene Expression -- drug effects
- Humans
- Leukocytes, Mononuclear -- drug effects
- Male
- Methylprednisolone -- pharmacology
- Middle Aged
- Mitoxantrone -- pharmacology
- Multiple Sclerosis -- blood
- Receptors, CXCR -- genetics
- Receptors, CXCR3 -- genetics
- Receptors, CXCR4 -- genetics
- Receptors, CXCR5 -- genetics
- Receptors, Interleukin-8A -- genetics
- Receptors, Interleukin-8B -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.